Episodic and Long-Term Costs of Acute Pancreatitis Requiring Hospitalization among Adults in US Clinical Practice
The cost of AP requiring hospitalization is high, for the treatment of both acute disease as well as associated long-term complications, which underscores the potential economic benefits from the prevention of this condition.
Authors
- Montserrat Vera Llonch
- Emily Kutrieb
- Derek Weycker (ORCID: https://orcid.org/0000-0002-5405-2215)
- Aaron Moynahan
- Asia Sikora Kessler (ORCID: https://orcid.org/0000-0001-9417-6637)
- Lisa Abramovitz
- Seth J. Baum (ORCID: https://orcid.org/0000-0003-1202-8126)
- Daniel Soffer (ORCID: https://orcid.org/0000-0002-0041-4954)
Institutions
- Prevea Health (US)
- Pieris Pharmaceuticals (United States) (US)
- University of Pennsylvania Health System (US)
Publication Details
- Journal
- Pancreas
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1097/mpa.0000000000002599
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00